SEC 13F Intelligence

Hanseatic Management Services Inc / PCRX

Hanseatic Management Services Inc’s Pacira Biosciences Inc Position

Does Hanseatic Management Services Inc own Pacira Biosciences Inc (PCRX)? Not currently — the last reported position was 8.0K shares worth $610,000 in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$610,000
Q1 2022
Shares
8.0K
% of Portfolio
+1.05%
Quarters Held
1
position exited

Position History PCRX

Reported value by quarter
Q1 ’22: $610,000Q1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20228.0K$610,000+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hanseatic Management Services Inc’s full portfolio or all institutional holders of PCRX.